Trametinib for progressive pediatric low-grade gliomas

ConclusionTrametinib appears to be a suitable option for refractory pediatric low-grade glioma and warrants further investigations in case of progression.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research